GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Keeps Biopharma Inc (XKRX:256940) » Definitions » Research & Development

Keeps Biopharma (XKRX:256940) Research & Development : ₩610 Mil (TTM As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Keeps Biopharma Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Keeps Biopharma's Research & Development for the three months ended in Mar. 2025 was ₩0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ₩610 Mil.

Keeps Biopharma Research & Development Historical Data

The historical data trend for Keeps Biopharma's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Keeps Biopharma Research & Development Chart

Keeps Biopharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 829.90 2,809.92 2,164.09 1,450.20 801.38

Keeps Biopharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 191.32 220.48 216.17 173.42 -

Keeps Biopharma Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩610 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Keeps Biopharma  (XKRX:256940) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Keeps Biopharma Research & Development Related Terms

Thank you for viewing the detailed overview of Keeps Biopharma's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Keeps Biopharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Keeps Biopharma Inc (XKRX:256940) » Definitions » Research & Development
Comparable Companies
XKRX:226320 XKRX:950140 XKRX:214420 XKRX:092730 XKRX:064090 XKRX:003350 XKRX:123330 XKRX:078520 XKRX:439090 XKRX:237880 PG XPAR:OR LSE:ULVR CL BOM:500696 KVUE KMB LSE:RKT XTER:HEN3 XTER:BEI
Traded in Other Exchanges
N/A
Address
507-1, Seshin Jonghap Sangga, 698-1, Deungchondong Gangseogu, Seoul, KOR
Website
http://www.kpscorp.net
Keeps Biopharma Inc Formerly KPS Corp manufactures cleanroom consumables. Its products include wiper, poly tape, sticky roll and adhesive roll.

Keeps Biopharma Headlines

No Headlines